These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3012164)
21. Relationship between inhibition of pressor response to angiotensin I and blood concentration of captopril following a single oral administration to dogs. Koike H; Ikeda T; Komai T; Kawai K; Miyamota M; Shindo H Eur J Pharmacol; 1981 Feb; 69(4):447-51. PubMed ID: 6265226 [TBL] [Abstract][Full Text] [Related]
22. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology. DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187 [TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of benazepril, an angiotensin-converting enzyme inhibitor, as studied in conscious normotensive dogs. Ishibashi T; Tatebe S; Mitomi A; Tanaka M; Imai S Cardiovasc Drugs Ther; 1991 Jun; 5(3):635-41. PubMed ID: 1652276 [TBL] [Abstract][Full Text] [Related]
24. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs. Miura K; Abe Y; Yamamoto K J Pharmacol Exp Ther; 1982 Jul; 222(1):246-50. PubMed ID: 6177851 [TBL] [Abstract][Full Text] [Related]
25. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats. Vollmer RR; Boccagno JA Eur J Pharmacol; 1977 Sep; 45(2):117-25. PubMed ID: 198216 [TBL] [Abstract][Full Text] [Related]
26. Hypotensive effect of captopril, an angiotensin converting enzyme inhibitor in pentobarbital anesthetized dogs. Satoh S; Fujisawa S; Tanaka R; Nakai K Jpn J Pharmacol; 1980 Feb; 30(1):112-5. PubMed ID: 6249947 [No Abstract] [Full Text] [Related]
27. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure. Shannon RP; Friedrich S; Mathier M; Knight DR Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029 [TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism of captopril induced hypotension in rats. Clarke DE; Wagner LB; Wagner LA Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011 [TBL] [Abstract][Full Text] [Related]
29. Effect of angiotensin-converting enzyme inhibition by captopril on cardiac output, coronary blood flow, and systemic arterial blood pressure in the intact and in the bilaterally nephrectomized rabbit. Ohmae M; Rabkin SW; Fung HY J Cardiovasc Pharmacol; 1981; 3(5):1060-7. PubMed ID: 6168851 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the time course of action of captopril on angiotensin-converting enzyme with the time course of its antihypertensive effect. Velletri P; Bean BL J Cardiovasc Pharmacol; 1981; 3(5):1068-81. PubMed ID: 6168852 [TBL] [Abstract][Full Text] [Related]
32. Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs. Vollmer RR; Boccagno JA; Harris DN; Murthy VS Eur J Pharmacol; 1978 Sep; 51(1):39-45. PubMed ID: 212276 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of central angiotensin I conversion by oral captopril. Marson O; Ribeiro AB; Tufik S; Kohlmann O; Ramos OL Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920 [TBL] [Abstract][Full Text] [Related]
34. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322 [TBL] [Abstract][Full Text] [Related]
35. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390 [TBL] [Abstract][Full Text] [Related]
36. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation. Forhead AJ; Whybrew K; Hughes P; Broughton Pipkin F; Sutherland M; Fowden AL Br J Pharmacol; 1996 Sep; 119(2):393-401. PubMed ID: 8886426 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. Laubie M; Schiavi P; Vincent M; Schmitt H J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763 [TBL] [Abstract][Full Text] [Related]
38. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE). DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654 [TBL] [Abstract][Full Text] [Related]
39. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
40. The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats. Spertini F; Brunner HR; Waeber B; Gavras H Circ Res; 1981 May; 48(5):612-8. PubMed ID: 6260396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]